A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 25
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : LMP1
Long Form : latent infection membrane protein 1
No. Year Title Co-occurring Abbreviation
2015 Characterization of the rapamycin-inducible EBV LMP1 activation system. EBV, JNK, LCL, MAPK, TNFR
2014 Role of Ca2+/calmodulin-dependent kinase II-IRAK1 interaction in LMP1-induced NF-kappaB activation. CaMKII, EBV, IKKalpha, IL-1, KO, MEFs
2013 Lupeol is one of active components in the extract of Chrysanthemum indicum Linne that inhibits LMP1-induced NF-kappaB activation. CIE, EBV, HFF, LCL
2012 The extract of Chrysanthemum indicum Linne inhibits EBV LMP1-induced NF-kappaB activation and the viability of EBV-transformed lymphoblastoid cell lines. CIE, EBV, HFF, LCLs
2011 Epstein-Barr virus-associated primary central nervous system lymphoma in a patient with adult T-cell leukemia / lymphoma. ATLL, CNS, EBER, EBNA2, EBV, HTLV-I, PCNSL
2008 IRF7 activation by Epstein-Barr virus latent membrane protein 1 requires localization at activation sites and TRAF6, but not TRAF2 or TRAF3. EBV, IRF7
2007 LMP1 TRAFficking activates growth and survival pathways. CTAR1 and 2, EBV, TES1 and 2, TM, TNFR, TRADD
2004 Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation. EBV, MEFs, MIP, TNF
2003 Epstein-Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-kappaB2 to p52 via an IKKgamma/NEMO-independent signalling pathway. EBV, IKKs
10  2003 Oncogenes, tumor suppressors and p52 NF-kappaB. EBV
11  2003 TRAF1 is a critical regulator of JNK signaling by the TRAF-binding domain of the Epstein-Barr virus-encoded latent infection membrane protein 1 but not CD40. EBV, MAPK, NPC, TNF, TRADD, TRAFs
12  2002 The Epstein-Barr virus latent membrane protein 1 putative Janus kinase 3 (JAK3) binding domain does not mediate JAK3 association or activation in B-lymphoma or lymphoblastoid cell lines. EBV, JAK3, LCLs, STAT3
13  2002 The oncogenic protein kinase Tpl-2/Cot contributes to Epstein-Barr virus-encoded latent infection membrane protein 1-induced NF-kappaB signaling downstream of TRAF2. ---
14  2000 Thermodynamic characterization of the interaction between TRAF2 and tumor necrosis factor receptor peptides by isothermal titration calorimetry. EBV, ITC, TNFR, TRAFs
15  1999 Epstein-barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-kappaB. EBV
16  1999 Prevalence of Epstein-Barr virus in oral squamous cell carcinoma. EBER, EBV, ISH, OSCC, PCR
17  1998 Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-kappaB through a pathway that includes the NF-kappaB-inducing kinase and the IkappaB kinases IKKalpha and IKKbeta. NIK, TNFR
18  1997 [Regulation of apoptosis by the latent infection membrane protein 1 of Epstein-Barr virus]. EBV
19  1996 Frequent expression of interleukin-10 by Epstein-Barr virus-harboring tumor cells of Hodgkin's disease. ARL, EBV, HD, IL
20  1996 Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein. CT, TNFR
21  1996 [Anti-apoptotic function of the Epstein-Barr virus LMP1 and BHRF1 proteins]. EBV
22  1995 The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. EBV, LAP1, TRAF2
23  1994 A Ca2+/calmodulin-dependent protein kinase, CaM kinase-Gr, expressed after transformation of primary human B lymphocytes by Epstein-Barr virus (EBV) is induced by the EBV oncogene LMP1. EBV
24  1993 Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. EBV
25  1992 Phenotypes of Epstein-Barr virus LMP1 deletion mutants indicate transmembrane and amino-terminal cytoplasmic domains necessary for effects in B-lymphoma cells. EBV